The story of Viagra, initially marketed by copyright, presents a intricate case study for investors considering the pharmaceutical arena . Despite its early success and impact of countless in earnings , the intellectual property expiration has opened the floodgates for generic medications, substantially diminishing earnings prospects . This shift r